Sanofi
PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
Last updated:
Abstract:
A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
Status:
Application
Type:
Utility
Filling date:
6 Jul 2020
Issue date:
11 Feb 2021